Sunshine Biopharma Inc (SBFM)
0.93
-0.28
(-23.14%)
USD |
NASDAQ |
Apr 24, 16:00
0.879
-0.05
(-5.48%)
Pre-Market: 08:54
Sunshine Biopharma Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 8.977 |
| September 30, 2021 | -3.011 |
| June 30, 2021 | -2.897 |
| March 31, 2021 | -2.529 |
| December 31, 2020 | -2.004 |
| September 30, 2020 | -1.831 |
| June 30, 2020 | -1.033 |
| March 31, 2020 | -0.9055 |
| December 31, 2019 | -0.9731 |
| September 30, 2019 | -1.012 |
| Date | Value |
|---|---|
| June 30, 2019 | -0.954 |
| March 31, 2019 | -5.402 |
| December 31, 2018 | -17.09 |
| September 30, 2018 | 20.39 |
| June 30, 2018 | -4.610 |
| March 31, 2018 | -2.732 |
| December 31, 2017 | -1.399 |
| September 30, 2017 | -1.672 |
| June 30, 2017 | -0.6563 |
| March 31, 2017 | -0.9781 |
| December 31, 2016 | -1.13 |
| September 30, 2016 | 0.7717 |
| June 30, 2016 | -0.5911 |
| March 31, 2016 | -3.108 |
| December 31, 2015 | -1.910 |
| September 30, 2015 | -1.257 |
| June 30, 2015 | -1.472 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-3.011
Minimum
Sep 2021
8.977
Maximum
Dec 2021
-0.4301
Average
-0.9055
Median
Mar 2020
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 27.35M |
| Total Liabilities (Quarterly) | 6.140M |
| Shareholders Equity (Quarterly) | 21.21M |
| Current Ratio | 4.483 |